In keeping with a national effort to expand and improve innovative clinical trials, Winship opened a new Phase I Clinical Trials Unit that is the largest unit in Georgia dedicated to the critical phase of testing new cancer therapies. Located on the fourth floor of the Emory University Hospital Tower, the new Winship Phase I Unit is triple the size of the old unit and expands access for patients to the critical phase of testing new cancer therapies.
The new unit was designed to be both patient-focused and able to support the painstaking demands of rigorous clinical research. The new unit features 15 private treatment bays, four clinic rooms, plus many key support resources, including a dedicated lab for processing patient blood work, a dedicated secure medication room, computer workspace for research staff, and a "fast track" bay with three chairs for rapid use by patients who might only require a short visit such as a research lab draw.
The design of the new space was guided by a multi-disciplinary team of patients, nurses, physicians, and research staff. While enabling staff to treat more patients with the highest standards of safety and efficiency, the new unit also prioritizes the comfort of patients and caregivers with specially-designed treatment areas, furniture, and amenities. The treatment bays all have full length windows that provide light as well as campus and skyline views.
"The new Phase I Clinical Trials Unit is a tremendous resource that will enable the very best research in the clinical setting," says Walter J. Curran, Jr., MD, executive director of Winship Cancer Institute.
The Winship Phase I Clinical Trials Unit will be open Monday through Friday, 7 am to 7:30 pm. Donald Harvey, Pharm D, will continue to serve as the Phase I section director with Colleen Lewis, NP, as the lead advanced practice provider.